Literature DB >> 11078797

Molecular analysis of the h-warts/LATS1 gene in human breast cancer.

N Morinaga1, Y Shitara, Y Yanagita, T Koida, M Kimura, T Asao, I Kimijima, S Takenoshita, T Hirota, H Saya, H Kuwano.   

Abstract

Loss of heterozygosity (LOH) on chromosome 6q is often observed in breast cancer, suggesting the existence of a putative tumor suppressor. Recently, a human homolog of the Drosophila warts tumor suppressor gene, h-warts/LATS1, was identified and mapped at chromosome 6q24-25.1. Mutation analysis of the h-warts/LATS1 was performed using 25 breast cancer tissues by RT-PCR SSCP analysis. Although LOH of the h-warts/LATS1 was found in one patient, no mutations were found. Two polymorphisms were found, but neither of them caused amino acid substitutions. Further investigations are necessary to elucidate the role of the h-warts/LATS1 gene in the carcinogenesis of breast cancer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11078797     DOI: 10.3892/ijo.17.6.1125

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  10 in total

1.  Underexpression of LATS1 TSG in colorectal cancer is associated with promoter hypermethylation.

Authors:  Piotr M Wierzbicki; Krystian Adrych; Dorota Kartanowicz; Marcin Stanislawowski; Anna Kowalczyk; Janusz Godlewski; Iwona Skwierz-Bogdanska; Krzysztof Celinski; Tomasz Gach; Jan Kulig; Bartlomiej Korybalski; Zbigniew Kmiec
Journal:  World J Gastroenterol       Date:  2013-07-21       Impact factor: 5.742

2.  Implication of snoRNA U50 in human breast cancer.

Authors:  Xue-Yuan Dong; Peng Guo; Jeff Boyd; Xiaodong Sun; Qunna Li; Wei Zhou; Jin-Tang Dong
Journal:  J Genet Genomics       Date:  2009-08       Impact factor: 4.275

Review 3.  LIM kinases: function, regulation and association with human disease.

Authors:  Rebecca W Scott; Michael F Olson
Journal:  J Mol Med (Berl)       Date:  2007-02-10       Impact factor: 5.606

4.  Down-regulation of Yes Associated Protein 1 expression reduces cell proliferation and clonogenicity of pancreatic cancer cells.

Authors:  Caroline H Diep; Kelly M Zucker; Galen Hostetter; Aprill Watanabe; Chengcheng Hu; Ruben M Munoz; Daniel D Von Hoff; Haiyong Han
Journal:  PLoS One       Date:  2012-03-01       Impact factor: 3.240

5.  Loss of large tumor suppressor 1 promotes growth and metastasis of gastric cancer cells through upregulation of the YAP signaling.

Authors:  Jing Zhang; Ge Wang; Shao-Jun Chu; Jin-Shui Zhu; Rui Zhang; Wen-Wen Lu; Li-Qiong Xia; Yun-Min Lu; Wei Da; Qun Sun
Journal:  Oncotarget       Date:  2016-03-29

6.  Clinicopathological Significance of Large Tumor Suppressor (LATS) Expression in Gastric Cancer.

Authors:  Myoung Won Son; Geum Jong Song; Si-Hyong Jang; Soon Auck Hong; Mee-Hye Oh; Ji-Hye Lee; Moo Jun Baek; Moon Soo Lee
Journal:  J Gastric Cancer       Date:  2017-12-26       Impact factor: 3.720

7.  LATS1 suppresses proliferation and invasion of cervical cancer.

Authors:  Jihong Deng; Wen Zhang; Shuangyue Liu; Hongmei An; Lu Tan; Lisha Ma
Journal:  Mol Med Rep       Date:  2017-02-08       Impact factor: 2.952

8.  Transcriptional activation of the Lats1 tumor suppressor gene in tumors of CUX1 transgenic mice.

Authors:  Rania Siam; Ryoko Harada; Chantal Cadieux; Robert Battat; Charles Vadnais; Alain Nepveu
Journal:  Mol Cancer       Date:  2009-08-05       Impact factor: 27.401

9.  miR-363 confers taxane resistance in ovarian cancer by targeting the Hippo pathway member, LATS2.

Authors:  Zeinab Mohamed; Mohamed Kamel Hassan; Safwat Okasha; Takashi Mitamura; Sarah Keshk; Yusuke Konno; Tatsuya Kato; Sherif F El-Khamisy; Yusuke Ohba; Hidemichi Watari
Journal:  Oncotarget       Date:  2018-07-10

10.  Outcome in serous ovarian cancer is not associated with LATS expression.

Authors:  Céline Montavon; Gregor R Stricker; Andreas Schoetzau; Viola Heinzelmann-Schwarz; Francis Jacob; André Fedier
Journal:  J Cancer Res Clin Oncol       Date:  2019-10-04       Impact factor: 4.553

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.